首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Structural Pharmacology of Voltage-Gated Sodium Channels
Institution:1. Department of Structural Biology, Genentech, South San Francisco, CA 94080, USA;2. Department of Biochemical and Cellular Pharmacology, Genentech, South San Francisco, CA 94080, USA;1. Department of Structural Biology, Genentech, South San Francisco, CA 94080, USA;2. Department of Biochemical and Cellular Pharmacology, Genentech, South San Francisco, CA 94080, USA;3. Department of Neuroscience, Genentech, South San Francisco, CA 94080, USA;4. Department of Biomolecular Resources, Genentech, South San Francisco, CA 94080, USA
Abstract:Voltage-gated sodium (NaV) channels initiate and propagate action potentials in excitable tissues to mediate key physiological processes including heart contraction and nervous system function. Accordingly, NaV channels are major targets for drugs, toxins and disease-causing mutations. Recent breakthroughs in cryo-electron microscopy have led to the visualization of human NaV1.1, NaV1.2, NaV1.4, NaV1.5 and NaV1.7 channel subtypes at high-resolution. These landmark studies have greatly advanced our structural understanding of channel architecture, ion selectivity, voltage-sensing, electromechanical coupling, fast inactivation, and the molecular basis underlying NaV channelopathies. NaV channel structures have also been increasingly determined in complex with toxin and small molecule modulators that target either the pore module or voltage sensor domains. These structural studies have provided new insights into the mechanisms of pharmacological action and opportunities for subtype-selective NaV channel drug design. This review will highlight the structural pharmacology of human NaV channels as well as the potential use of engineered and chimeric channels in future drug discovery efforts.
Keywords:Sodium channel  Pharmacology  Structure  Drug discovery
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号